HMB-001: A Novel Bispecific Antibody Accumulating and Targeting Endogenous FVIIa to Activated Platelets for Subcutaneous Prophylaxis in Multiple Bleeding Disorders Including Glanzmann Thrombasthenia.
Gandhi, P.S., Zivkovic, M., Oestergaard, H., Bonde, A.C., Loevgreen, M.N., Schluckebier, G., Johansson, E., Rea, C.J., Soerensen, B., Schutgens, R.E., Urbanus, R.T., Faber, J.H.To be published.